A detailed history of Marathon Partners Equity Management, LLC transactions in Haleon PLC stock. As of the latest transaction made, Marathon Partners Equity Management, LLC holds 475,000 shares of HLN stock, worth $4.91 Million. This represents 7.3% of its overall portfolio holdings.

Number of Shares
475,000
Previous 580,000 18.1%
Holding current value
$4.91 Million
Previous $4.83 Million 19.09%
% of portfolio
7.3%
Previous 8.47%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 13, 2024

SELL
$7.78 - $8.62 $816,900 - $905,099
-105,000 Reduced 18.1%
475,000 $3.91 Million
Q2 2023

Aug 11, 2023

BUY
$8.04 - $9.0 $1.19 Million - $1.33 Million
147,500 Added 34.1%
580,000 $4.86 Million
Q1 2023

May 12, 2023

BUY
$7.57 - $8.37 $3.27 Million - $3.62 Million
432,500 New
432,500 $3.52 Million

Others Institutions Holding HLN

About Haleon plc


  • Ticker HLN
  • Exchange
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 4,617,290,240
  • Market Cap $47.7B
  • Description
  • Haleon plc engages in the research and development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides therapeutic oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, mineral...
More about HLN
Track This Portfolio

Track Marathon Partners Equity Management, LLC Portfolio

Follow Marathon Partners Equity Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Marathon Partners Equity Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Marathon Partners Equity Management, LLC with notifications on news.